Higashikuni Lab
Higashikuni Lab
Home
Projects
Posts
Talks
People
Publications
Contact
Light
Dark
Automatic
RNA Metabolism and Modification
RNA Metabolism and Modification in Cardiovascular disease
Deciphering RNA metabolism and modification in pathogenic mechanism of heart failure for development of novel therapeutic strategies.
Mitigation of Doxorubicin Cardiotoxicity With Synergistic miRNA Combinations Identified Using Combinatorial Genetics en masse (CombiGEM)
Background, Cardiomyocyte loss occurs in acute and chronic cardiac injury, including cardiotoxicity due to chemotherapeutics like …
Yasutomi Higashikuni, M.D., Ph.D., FESC
,
Colin Platt
,
Margaret H Hastings
,
William C W Chen
,
Justin R B Guerra
,
Takeshi Tokuyama
,
Fuad Gandhi Torizal
,
Wenhao Liu, M.D.
,
Takumi Obana
,
Abraham L Bayer
,
Hannah Whipple
,
lexandra Kuznetsov
,
Ashish Yeri
,
Cole Turissini
,
Robert R Kitchen
,
Kota Shibayama
,
Takayoshi Matsumura
,
Norihiko Takeda
,
Hideki Uosaki
,
Aarti H Asnani
,
Timothy K Lu
,
Anthony Rosenzweig
Project
DOI
Just published in JACC CardioOncology!!
Mitigation of Doxorubicin Cardiotoxicity With Synergistic miRNA Combinations Identified Using Combinatorial Genetics en masse (CombiGEM)
Yasutomi Higashikuni, M.D., Ph.D., FESC
Last updated on Jun 2, 2025
1 min read
Lab
Project
ISHR2025 Aging and inflammatory signaling in heart disease
We will discuss aging and inflammatory signaling in heart disease.
May 12, 2025 8:30 AM — 10:30 AM
Nara
Yasutomi Higashikuni, M.D., Ph.D., FESC
Project
Project
Project
CREATE-GLOBAL 2025 Inflammatory signaling in heart disease
We will discuss how inflammation causes heart failure.
May 10, 2025 10:00 AM — 5:30 PM
Osaka
Yasutomi Higashikuni, M.D., Ph.D., FESC
Project
Project
Project
Japan Society for Vascular Failure 2025 Heart-Vessel Interaction
We will discuss Heart-Vessel interaction in cardiovascular disease.
Apr 27, 2025 1:20 PM — 2:40 PM
Saga
Yasutomi Higashikuni, M.D., Ph.D., FESC
Project
Project
Project
How Inflammation Causes Heart Failure
We will discuss how inflammation is initiated in the stressed heart and causes heart failure.
Dec 16, 2023 9:00 AM — 10:30 AM
Osaka
Yasutomi Higashikuni, M.D., Ph.D., FESC
Project
Project
Novel Therapeutic Strategy for Cardiovascular Disease
Based on our basic research findings and clinical experience, we will discuss next-generation therapeutic strategy for cardiovascular disease.
Nov 11, 2023 9:00 AM — 6:00 PM
Tokyo, Online
Yasutomi Higashikuni, M.D., Ph.D., FESC
Project
Project
Project
Heart Failure and Inflammation
We will discuss how inflammation is initiated in the stressed heart and causes heart failure.
Oct 30, 2023 6:00 PM — 7:30 PM
Tokyo, Online
Yasutomi Higashikuni, M.D., Ph.D., FESC
Project
Project
Diabetes in Cardiovascular Medicine
Synthetic biology approach for the treatment of diabetes and cardiovascular disease will be discussed.
Sep 6, 2022 7:00 PM — 8:30 PM
Tokyo, Online
Yasutomi Higashikuni, M.D., Ph.D., FESC
Project
Project
Project
»
Cite
×